In conclusion, our findings reveal a novel mechanism wherein CAFs-secreted CXCL11 promotes NPC malignant progression by activating the CXCR3/PD-L1 signaling axis. The gene discussed is CXCR3; the disease is nasopharyngeal carcinoma.